Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A reveal a positive outlook: improved TiO2 and zircon volumes, cost reduction measures, and positive free cash flow projections. Despite some uncertainties, like FX issues and restructuring charges, the strategic focus on rare earths and market share gains from antidumping duties are promising. The market cap suggests moderate stock price sensitivity, leading to a likely positive stock price movement in the next two weeks.
Revenue $2.9 billion for the full year 2025, a year-over-year decline driven by unfavorable pricing, mix, and lower volumes in both TiO2 and zircon.
Loss from Operations $253 million for the full year 2025, impacted by $233 million of restructuring and other charges related to plant closures.
Net Loss $470 million for the full year 2025, including restructuring charges and tax expenses.
Adjusted EBITDA $336 million for the full year 2025, with an adjusted EBITDA margin of 11.6%, reflecting unfavorable pricing, mix, and higher production costs.
Free Cash Flow A use of $281 million for the full year 2025, including $341 million of capital expenditures.
TiO2 Volumes Reached their highest point of the year in Q4 2025, driven by anti-dumping duties and increased market share in India and other protected regions.
Zircon Volumes Increased 42% sequentially in Q4 2025, supported by customer restocking and resuming normal buying patterns.
Zircon Pricing Down 7% quarter-to-quarter in Q4 2025, compounded by unfavorable mix.
Adjusted EBITDA for Q4 2025 $57 million, a 56% decline year-over-year due to unfavorable pricing, higher production costs, and higher freight costs.
Total Debt $3.2 billion as of December 31, 2025, with net debt of $3 billion.
Liquidity $674 million as of December 31, 2025, including $199 million in cash and cash equivalents.
Capital Expenditures $341 million for the full year 2025, with 60% allocated to maintenance and safety and 40% to mining extensions in South Africa.
TiO2 volumes: Reached their highest point of the year in Q4 2025, showing a structural change in global TiO2 trade flows due to anti-dumping duties.
Zircon volumes: Concluded the year positively, supported by customers restocking and resuming normal buying patterns.
Rare earth strategy: Advanced with conditional nonbinding financing for a cracking and leaching facility in Australia, progressing feasibility studies and evaluating refining capacity.
Market share gains: Increased in India, Latin America, and the Middle East, supported by anti-dumping measures.
TiO2 pricing: Prices were lower in Q4 2025 but are now increasing, with positive momentum in higher-priced regions.
Zircon pricing: Faced headwinds in Q4 2025 but price increases are expected to be implemented in Q2 2026.
Safety performance: Achieved the lowest overall injury rate in more than a decade in 2025.
Cost improvement program: Exited 2025 with over $90 million in run-rate savings, tracking towards $125-$175 million by the end of 2026.
Cash flow and inventory management: Generated $53 million in free cash flow in Q4 2025 through disciplined inventory management.
Plant closures: Closed two pigment plants (Fuzhou in China and Botlek) to streamline operations and improve cost structure.
Debt management: Executed a $400 million senior secured note offering to increase liquidity and maintain a strong financial position.
Rare earths initiative: Focused on moving downstream into separated rare earth oxides while maintaining capital discipline.
Market Downturn in China: The prolonged market downturn in China, weak domestic demand, overcapacity, and unsustainable pricing levels have led to the closure of the Fuzhou plant. This reflects challenges in maintaining profitability in the region.
Pricing and Mix Headwinds: Lower TiO2 and zircon prices, along with unfavorable mix, have negatively impacted revenue and profitability. This includes a 4% decline in TiO2 prices and a 7% decline in zircon prices in Q4 2025.
Production Cost Challenges: Higher production costs due to actions like bringing forward maintenance, idling assets, and additional downtime have negatively impacted EBITDA. These measures, while aimed at cash preservation, have reduced near-term profitability.
Debt and Interest Rate Exposure: The company has a total debt of $3.2 billion, with a weighted average interest rate of 6%. While most interest rates are fixed, the high debt level poses a financial risk, especially in a challenging market environment.
Regulatory and Legal Risks in India: A temporary halt in the collection of anti-dumping duties in India has shifted volumes back to China, impacting market share and revenue. The resolution of this issue remains uncertain.
Economic and Currency Volatility: FX volatility, particularly in the Australian dollar and South African rand, has created a $10 million headwind in Q1 2026. This adds financial uncertainty and impacts profitability.
Operational Restructuring Costs: The closures of the Botlek and Fuzhou plants have resulted in $233 million in restructuring and other charges, impacting financial performance.
Supply Chain and Inventory Management: Efforts to reduce inventory levels and manage working capital have been successful but have also led to temporary reductions in production, impacting EBITDA.
TiO2 Pricing and Volume: TiO2 pricing is expected to increase by approximately 2% to 4% sequentially in Q1 2026, driven by price increases and a shift in mix towards higher-value regions. TiO2 volumes are expected to remain relatively flat sequentially, with growth in all regions except Asia due to temporary market dynamics in India.
Zircon Pricing and Volume: Zircon volumes are expected to mirror the solid performance of Q4 2025. Zircon pricing has stabilized in Q1 2026, and price increases announced for Q2 2026 are expected to be implemented.
Free Cash Flow: The company expects to generate positive free cash flow for the full year 2026, supported by working capital improvements and cost-saving initiatives.
Capital Expenditures: Capital expenditures are projected to be approximately $260 million in 2026, with a focus on maintenance, safety, and strategic projects like rare earth initiatives.
Cost Improvement Program: The sustainable cost improvement program is expected to deliver significant savings, with a run rate target of $125 million to $175 million by the end of 2026.
Rare Earth Strategy: The company is advancing its rare earth strategy, including feasibility studies and stakeholder engagement, to develop a growth platform leveraging its existing mining footprint.
Market Recovery and Earnings Potential: The company anticipates a step-change in earnings potential as market fundamentals improve, supported by pricing recovery in TiO2 and zircon, cost structure improvements, and operational efficiencies.
Dividends Paid in 2025: $48 million was returned to shareholders in the form of dividends.
The earnings call summary and Q&A reveal a positive outlook: improved TiO2 and zircon volumes, cost reduction measures, and positive free cash flow projections. Despite some uncertainties, like FX issues and restructuring charges, the strategic focus on rare earths and market share gains from antidumping duties are promising. The market cap suggests moderate stock price sensitivity, leading to a likely positive stock price movement in the next two weeks.
The earnings call reflects a mixed sentiment. While there are positives such as growth in India, strategic cost reductions, and potential market opportunities in Brazil and Saudi Arabia, there are also concerns. These include weaker pigment and zircon volumes, idling of facilities, and the need for partnerships and capital in rare earths. Additionally, management's vague responses on several key issues contribute to uncertainty. Given the company's market cap, these mixed signals suggest a neutral stock price movement over the next two weeks.
The earnings call reveals several concerns: a dividend cut by 60% to maintain financial flexibility, a 2% decline in TiO2 volumes, and increased freight costs due to inventory repositioning. While there are positive elements like rare earth sales and potential duties benefits, the muted demand in key regions and lack of specific guidance on pricing and secured debt capacity contribute to a negative outlook. The market cap of approximately $2.46 billion suggests moderate volatility, supporting a negative stock price prediction of -2% to -8% over the next two weeks.
The earnings call highlights several concerns: a significant net loss, high debt levels, and a decline in adjusted EBITDA. Despite some revenue growth, the financial health is weak, with a high net leverage ratio and significant restructuring costs. The Q&A revealed uncertainties in market share recapture and cost impacts. While there are optimistic growth expectations in TiO2 and zircon markets, the overall sentiment remains negative due to financial struggles and uncertainties. Given the mid-cap size, the stock is likely to react negatively, potentially falling between -2% to -8%.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.